drugset / Trial / NCT00003273

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NCT00003273

Phase 2 Withdrawn NYU Langone Health
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of different regimens of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed brain tumor.

Timeline

Start
1997-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule Intravenous
Subject Cisplatin Other / unclassified Intravenous
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Etoposide Small molecule Intravenous
Subject Methotrexate Small molecule Intravenous
Subject Temozolomide Small molecule Oral
Subject Thiotepa Other / unclassified Intravenous
Subject Vincristine Small molecule Intravenous
Background Leucovorin Small molecule Oral
Background filgrastim Protein / enzyme biologic Subcutaneous